Impact of immunosuppressive agents on components of the metabolic syndrome and hepatic steatosis
| Class of agent | Hypertension | Dyslipidaemia | DM | Weight gain | Hepatic steatosis |
| Corticosteroids | + | + | ++ | ++ | ++ |
| CNI | ++ | ++ | ++ | + | – |
| Antimetabolites | – | – | – | – | – |
| mTORi | – | +++ | +/− | – | – |
CNI, calcineurin inhibitor; mTORi, mammalian target of rapamycin inhibitors.